Source: Annual Congress 2001 - Novel approaches to treatment of lung disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. L. Pukhalsky, G. V. Shmarina (Moscow, Russia). Successful treatment of lung inflammation is associated with elevation of lymphocyte sensitivity to glucocorticoids. Eur Respir J 2001; 16: Suppl. 31, 2913

Member's Comments

No comment yet.

Related content which might interest you: Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Standard therapy increases the sensitivity of peripheral blood lymphocytes to glucocorticoids in cystic fibrosis but not in severe asthma Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 Oxidized-polymers of Z-AT are associated with exaggerated pulmonary inflammation post lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Effects of corticosteroid or montelukast associated to iNOS inhibitior on inflammation and remodelling of distal lung in animals with chronic inflammation Source: Annual Congress 2011 - Translational models of disease Year: 2011 Effect of corticosteroids on inflammatory markers in patients with severe cap and high inflammatory response according to presence of lymphopenia Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019 Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Expression of stress genes in circulating leucocytes: response to the systemic inflammation in patients with severe pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 231s Year: 2004 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Eur Respir Rev 2006; 15: 207-208 Year: 2006 Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Increased propensity for apoptosis and decreased Bcl-2 in peripheral blood T-cells from COPD patients - effect of corticosteroids? Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Increased lung neutrophil apoptosis and inflammation resolution Source: Eur Respir J 2012; 39: 789-790 Year: 2012 Increased lung neutrophil apoptosis and inflammation resolution Source: Eur Respir J 2012; 39: 790-791 Year: 2012 Selective inhibition of RANTES-mediated recruitment combined with elimination of cells into the airway lumen explains resolution of lung eosinophilia by steroids Source: Eur Respir J 2002; 20: Suppl. 38, 169s Year: 2002 Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Severe asthma in old patients is characterized by signs of immunosuppression and by lymphocyte resistance to glucocorticoids Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012